ProKidney (PROK) News Today $0.86 -0.13 (-13.02%) Closing price 04:00 PM EasternExtended Trading$0.95 +0.09 (+10.27%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Hennion & Walsh Asset Management Inc. Has $740,000 Stake in ProKidney Corp. (NASDAQ:PROK)Hennion & Walsh Asset Management Inc. raised its position in ProKidney Corp. (NASDAQ:PROK - Free Report) by 48.5% during the first quarter, according to its most recent filing with the SEC. The firm owned 844,277 shares of the company's stock after purchasing an additional 275,630 shares during theJune 8, 2025 | marketbeat.comProKidney Reports First Quarter 2025 Financial Results and Business HighlightsMay 12, 2025 | globenewswire.comPROKIDNEY Earnings Preview: Recent $PROK Insider Trading, Hedge Fund Activity, and MoreMay 9, 2025 | nasdaq.comProKidney (PROK) Expected to Announce Quarterly Earnings on FridayProKidney (NASDAQ:PROK) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-prokidney-corp-stock/)May 4, 2025 | marketbeat.comInsider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Purchases 387,393 Shares of StockApril 25, 2025 | insidertrades.comProKidney Corp. (NASDAQ:PROK) Insider Control Empresarial De Capital Acquires 100,000 SharesProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Control Empresarial De Capital purchased 100,000 shares of ProKidney stock in a transaction that occurred on Wednesday, April 16th. The shares were bought at an average price of $0.75 per share, with a total value of $75,000.00. Following the transaction, the insider now owns 73,430,330 shares of the company's stock, valued at $55,072,747.50. This trade represents a 0.14 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.April 20, 2025 | marketbeat.comInsider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Acquires 268,105 Shares of StockProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Control Empresarial De Capital acquired 268,105 shares of the business's stock in a transaction dated Monday, April 14th. The stock was purchased at an average price of $0.73 per share, with a total value of $195,716.65. Following the completion of the transaction, the insider now directly owns 72,862,330 shares of the company's stock, valued at $53,189,500.90. This trade represents a 0.37 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.April 18, 2025 | marketbeat.comProKidney Corp. (NASDAQ:PROK) Insider Buys $195,716.65 in StockApril 17, 2025 | insidertrades.comInsider Buying: ProKidney Corp. (NASDAQ:PROK) Insider Purchases 1,032,218 Shares of StockProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Control Empresarial De Capital bought 1,032,218 shares of the business's stock in a transaction on Thursday, April 10th. The stock was bought at an average cost of $0.61 per share, for a total transaction of $629,652.98. Following the purchase, the insider now directly owns 72,592,325 shares of the company's stock, valued at approximately $44,281,318.25. This trade represents a 1.44 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.April 16, 2025 | marketbeat.comControl Empresarial De Capital Buys 1,032,218 Shares of ProKidney Corp. (NASDAQ:PROK) StockApril 15, 2025 | insidertrades.comProKidney Corp.March 30, 2025 | wsj.comHere's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn SituationMarch 27, 2025 | finance.yahoo.comProKidney (NASDAQ:PROK) Announces Earnings ResultsProKidney (NASDAQ:PROK - Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.03). The business had revenue of $0.08 million for the quarter.March 19, 2025 | marketbeat.comProKidney reports FY24 EPS (62c), consensus (59c)March 17, 2025 | markets.businessinsider.comProKidney Reports Full Year 2024 Financial Results and Business HighlightsMarch 17, 2025 | globenewswire.comProKidney (PROK) Expected to Announce Quarterly Earnings on ThursdayProKidney (NASDAQ:PROK) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Down 2.7% - Here's WhyProKidney (NASDAQ:PROK) Stock Price Down 2.7% - Should You Sell?February 26, 2025 | marketbeat.comKuehn Law Encourages Investors of ProKidney Corp. to Contact Law FirmJanuary 31, 2025 | prnewswire.com2025 Will Be A Major Year For ProKidney's Rilparencel In CKD TreatmentJanuary 31, 2025 | seekingalpha.comUS Penny Stocks: 3 Picks With Market Caps Under $300MJanuary 27, 2025 | uk.finance.yahoo.comProKidney secures out-of-market buyer, $20.5 million price tag for Greensboro siteJanuary 24, 2025 | bizjournals.comProKidney (NASDAQ:PROK) Trading 8.7% Higher - Still a Buy?ProKidney (NASDAQ:PROK) Trading Up 8.7% - Should You Buy?January 21, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Buys New Stake in ProKidney Corp. (NASDAQ:PROK)Hennion & Walsh Asset Management Inc. purchased a new position in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 568,647 shares of the company's sJanuary 20, 2025 | marketbeat.comCautiously Optimistic: ProKidney’s Hold Rating Amid Accelerated Pathway and Trial DevelopmentsJanuary 16, 2025 | markets.businessinsider.comKuehn Law Encourages Investors of ProKidney Corp. to Contact Law FirmJanuary 7, 2025 | markets.businessinsider.comProKidney to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | markets.businessinsider.comGeode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK)Geode Capital Management LLC boosted its stake in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 102.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,203,934 shares of the company's stock afteJanuary 6, 2025 | marketbeat.comOne ProKidney Insider Raised Their Stake In The Previous YearJanuary 6, 2025 | finance.yahoo.comStories to Watch in 2025: Will ProKidney change its Winston-Salem plans after abandoning $458M Greensboro facility?January 2, 2025 | bizjournals.comProKidney (NASDAQ:PROK) Shares Gap Up - Still a Buy?ProKidney (NASDAQ:PROK) Shares Gap Up - Time to Buy?December 31, 2024 | marketbeat.comTBJ's Top 24 of '24: ProKidney backs out of Guilford deal, invests in W-S facilities (No. 4)December 30, 2024 | bizjournals.comProKidney (NASDAQ:PROK) Shares Down 2.5% - What's Next?ProKidney (NASDAQ:PROK) Shares Down 2.5% - What's Next?December 26, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Up 6.2% - Should You Buy?ProKidney (NASDAQ:PROK) Stock Price Up 6.2% - Time to Buy?December 24, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Up - Here's What HappenedProKidney (NASDAQ:PROK) Shares Gap Up - Here's WhyDecember 23, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 4.8% - Here's What HappenedProKidney (NASDAQ:PROK) Stock Price Down 4.8% - Here's WhyDecember 18, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stock Holdings in ProKidney Corp. (NASDAQ:PROK)Charles Schwab Investment Management Inc. grew its stake in ProKidney Corp. (NASDAQ:PROK - Free Report) by 150.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 749,718 shares of the company's stock afteDecember 17, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Up 5.9% - What's Next?ProKidney (NASDAQ:PROK) Stock Price Up 5.9% - Time to Buy?December 16, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading 8.4% Higher - What's Next?ProKidney (NASDAQ:PROK) Trading 8.4% Higher - Still a Buy?December 6, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading 5.4% Higher - Time to Buy?ProKidney (NASDAQ:PROK) Stock Price Up 5.4% - Here's What HappenedNovember 29, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) Shares Acquired by Suvretta Capital Management LLCSuvretta Capital Management LLC lifted its holdings in ProKidney Corp. (NASDAQ:PROK - Free Report) by 32.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,341,266 shares of the company's stock after purchasing an additional 3,000,000November 29, 2024 | marketbeat.comUS Penny Stocks To Watch: 3 Picks With Market Caps Under $500MNovember 26, 2024 | finance.yahoo.comProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare ConferenceNovember 26, 2024 | globenewswire.comProKidney purchases former Collins Aerospace facility, own HQ for $22.5MNovember 24, 2024 | bizjournals.comProKidney no longer coming to Greensboro, Chamber of Commerce confirmsNovember 21, 2024 | msn.comProKidney: Manufacturing expansion moving to W-S instead of GreensboroNovember 21, 2024 | bizjournals.comProKidney lists Greensboro property for sale, leaving future in city uncertainNovember 19, 2024 | msn.comFuture of development project promising hundreds of job now uncertainNovember 19, 2024 | msn.comProKidney lists building where it planned $458M investment for saleNovember 18, 2024 | bizjournals.comPharma company to expand Broward headquartersNovember 15, 2024 | bizjournals.comProKidney’s Progress in FDA Approval and Financial HealthNovember 13, 2024 | markets.businessinsider.com Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address PROK Media Mentions By Week PROK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PROK News Sentiment▼1.870.90▲Average Medical News Sentiment PROK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PROK Articles This Week▼12▲PROK Articles Average Week Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AUPH News WVE News NAGE News MLYS News RCUS News SYRE News AKBA News CVAC News ELVN News PAHC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PROK) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PROK Stock Free PROK Stock Alerts